Cargando…
Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-man...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016215/ https://www.ncbi.nlm.nih.gov/pubmed/24593656 http://dx.doi.org/10.1186/1472-6823-14-22 |
_version_ | 1782315469326254080 |
---|---|
author | Roelofsen, Yvonne Hendriks, Steven H Sieverink, Floor van Vugt, Michael van Hateren, Kornelis JJ Snoek, Frank J de Wit, Maartje Gans, Rijk OB Groenier, Klaas H van Gemert-Pijnen, Julia EWC Kleefstra, Nanne Bilo, Henk JG |
author_facet | Roelofsen, Yvonne Hendriks, Steven H Sieverink, Floor van Vugt, Michael van Hateren, Kornelis JJ Snoek, Frank J de Wit, Maartje Gans, Rijk OB Groenier, Klaas H van Gemert-Pijnen, Julia EWC Kleefstra, Nanne Bilo, Henk JG |
author_sort | Roelofsen, Yvonne |
collection | PubMed |
description | BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-management and reduce the burden on the healthcare system. METHODS: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed. DISCUSSION: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population. TRIAL REGISTRATION: Trial registration: NCT01570140. |
format | Online Article Text |
id | pubmed-4016215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40162152014-05-10 Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) Roelofsen, Yvonne Hendriks, Steven H Sieverink, Floor van Vugt, Michael van Hateren, Kornelis JJ Snoek, Frank J de Wit, Maartje Gans, Rijk OB Groenier, Klaas H van Gemert-Pijnen, Julia EWC Kleefstra, Nanne Bilo, Henk JG BMC Endocr Disord Study Protocol BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-management and reduce the burden on the healthcare system. METHODS: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed. DISCUSSION: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population. TRIAL REGISTRATION: Trial registration: NCT01570140. BioMed Central 2014-03-04 /pmc/articles/PMC4016215/ /pubmed/24593656 http://dx.doi.org/10.1186/1472-6823-14-22 Text en Copyright © 2014 Roelofsen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Roelofsen, Yvonne Hendriks, Steven H Sieverink, Floor van Vugt, Michael van Hateren, Kornelis JJ Snoek, Frank J de Wit, Maartje Gans, Rijk OB Groenier, Klaas H van Gemert-Pijnen, Julia EWC Kleefstra, Nanne Bilo, Henk JG Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title | Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title_full | Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title_fullStr | Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title_full_unstemmed | Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title_short | Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) |
title_sort | design of the e-vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-vitadm-1/zodiac-40) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016215/ https://www.ncbi.nlm.nih.gov/pubmed/24593656 http://dx.doi.org/10.1186/1472-6823-14-22 |
work_keys_str_mv | AT roelofsenyvonne designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT hendriksstevenh designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT sieverinkfloor designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT vanvugtmichael designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT vanhaterenkornelisjj designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT snoekfrankj designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT dewitmaartje designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT gansrijkob designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT groenierklaash designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT vangemertpijnenjuliaewc designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT kleefstrananne designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 AT bilohenkjg designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40 |